Skip to main content
. 2021 Jul 1;16(7):e0253520. doi: 10.1371/journal.pone.0253520

Table 1. Demographic and clinical characteristics of the BTT and the non-BTT groups at the time of transplantation.

All (n = 77) BTT (n = 41) Non-BTT (n = 36) P-value
Age, years, median (IQR) 53 (41–61) 55 (41–62) 51 (40–60) 0.358
Male, n (%) 51 (66.2) 26 (63.4) 25 (69.4) 0.577
BMI, kg/m2, median (IQR) 22.6 (19.4–24.9) 23.1 (20.2–25.4) 21.6 (16.7–24.4) 0.109
Blood type, n (%) 0.655
 A 27 (35.1) 17 (41.5) 10 (27.8)
 B 23 (29.9) 11 (26.8) 12 (33.3)
 O 14 (18.2) 7 (17.1) 7 (19.4)
 AB 13 (16.9) 6 (14.6) 7 (19.4)
Diagnosis, n (%) 0.479
 Interstitial lung disease 52 (67.5) 30 (73.2) 22 (61.1)
 Bronchiolitis obliterans syndromea 7 (9.1) 2 (4.9) 5 (13.9)
 Pulmonary vascular disease 5 (6.5) 3 (7.3) 2 (5.6)
 Others 13 (16.9) 6 (14.6) 7 (19.4)
SAPS II, median (IQR) 31 (12–39) 35 (31–49) 12 (7–19) <0.001
Type of transplantation 0.742
 Double-lung 67 (87.0) 35 (85.4) 32 (88.9)
 Heart-lung 10 (13.0) 6 (14.6) 4 (11.1)
Mechanical ventilation, n (%) <0.001
 Not required 27 (35.1) 1 (2.4) 26 (72.2)
 Intubated 13 (16.9) 10 (24.4) 3 (8.3)
 Tracheostomized 37 (48.1) 30 (73.2) 7 (19.4)
Mobilization, n (%) 60 (77.9) 31 (75.6) 29 (80.6) 0.602
Time to lung transplantation, days, median (IQR)
 From hospital admission 16 (1–39) 29 (14–42) 1 (0–25) <0.001
 From ICU admission 10 (0–25) 16 (10–30) 0 (0–2) <0.001
Ischemic time, h, median (IQR) 4.1 (3.8–4.5) 4.1 (3.9–4.6) 4.0 (3.7–4.5) 0.231
Primary graft dysfunction at 72 hours, n (%) 0.124
 Grade 0 or 1 26 (33.8) 11 (26.8) 15 (41.7)
 Grade 2 38 (49.4) 20 (48.8) 18 (50.0)
 Grade 3 13 (16.9) 10 (24.4) 3 (8.3)
AKI requiring dialysis, n (%) 18 (23.4) 11 (26.8) 7 (19.4) 0.445
Hypotension requiring vasopressors for > 24 hours, n (%) 17 (22.1) 12 (29.3) 5 (13.9) 0.105

AKI, acute kidney injury; BMI, body mass index; BTT, bridge to lung transplantation; IQR, interquartile range; SAPS II, simplified acute physiologic score II.

aSecondary to the previously treated hematologic malignancies.